Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Ovarian Neoplasms

  Free Subscription


1 Am J Surg Pathol
2 BMC Cancer
1 Br J Cancer
1 Cancer
1 Cancer Lett
1 Cancer Res
4 Gynecol Oncol
5 Hum Pathol
1 Int J Gynaecol Obstet
1 J Clin Oncol
1 Oncogene
1 Oncology
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Surg Pathol

  1. VANG R, Hannibal CG, Junge J, Frederiksen K, et al
    Long-term Behavior of Serous Borderline Tumors Subdivided Into Atypical Proliferative Tumors and Noninvasive Low-grade Carcinomas: A Population-based Clinicopathologic Study of 942 Cases.
    Am J Surg Pathol. 2017;41:725-737.
    PubMed     Text format     Abstract available

    BMC Cancer

  2. CHAN KKL, Siu MKY, Jiang YX, Wang JJ, et al
    Differential expression of estrogen receptor subtypes and variants in ovarian cancer: effects on cell invasion, proliferation and prognosis.
    BMC Cancer. 2017;17:606.
    PubMed     Text format     Abstract available

  3. TONG JG, Valdes YR, Sivapragasam M, Barrett JW, et al
    Spatial and temporal epithelial ovarian cancer cell heterogeneity impacts Maraba virus oncolytic potential.
    BMC Cancer. 2017;17:594.
    PubMed     Text format     Abstract available

    Br J Cancer

  4. WEISS GJ, Waypa J, Blaydorn L, Coats J, et al
    A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus).
    Br J Cancer. 2017;117:33-40.
    PubMed     Text format     Abstract available


  5. CRAGUN D, Weidner A, Lewis C, Bonner D, et al
    Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors.
    Cancer. 2017 Feb 9. doi: 10.1002/cncr.30621.
    PubMed     Text format     Abstract available

    Cancer Lett

  6. LAKSHMINARASIMHAN R, Andreu-Vieyra C, Lawrenson K, Duymich CE, et al
    Down-regulation of ARID1A is sufficient to initiate neoplastic transformation along with epigenetic reprogramming in non-tumorigenic endometriotic cells.
    Cancer Lett. 2017 May 5. pii: S0304-3835(17)30312.
    PubMed     Text format     Abstract available

    Cancer Res

  7. JOSEPHS DH, Bax HJ, Dodev T, Georgouli M, et al
    Anti-Folate Receptor-alpha IgE but not IgG Recruits Macrophages to Attack Tumors via TNFalpha/MCP-1 Signaling.
    Cancer Res. 2017;77:1127-1141.
    PubMed     Text format     Abstract available

    Gynecol Oncol

  8. MARTIN LP, Konner JA, Moore KN, Seward SM, et al
    Characterization of folate receptor alpha (FRalpha) expression in archival tumor and biopsy samples from relapsed epithelial ovarian cancer patients: A phase I expansion study of the FRalpha-targeting antibody-drug conjugate mirvetuximab soravtansine.
    Gynecol Oncol. 2017 Aug 24. pii: S0090-8258(17)31253.
    PubMed     Text format     Abstract available

  9. HERZOG TJ, Ison G, Alvarez RD, Balasubramaniam S, et al
    FDA ovarian cancer clinical trial endpoints workshop.
    Gynecol Oncol. 2017 Aug 24. pii: S0090-8258(17)31250.
    PubMed     Text format    

  10. DUAN H, Yan Z, Chen W, Wu Y, et al
    TET1 inhibits EMT of ovarian cancer cells through activating Wnt/beta-catenin signaling inhibitors DKK1 and SFRP2.
    Gynecol Oncol. 2017 Aug 26. pii: S0090-8258(17)31248.
    PubMed     Text format     Abstract available

  11. GOFF BA, Agnew K, Neradilek MB, Gray HJ, et al
    Combining a symptom index, CA125 and HE4 (triple screen) to detect ovarian cancer in women with a pelvic mass.
    Gynecol Oncol. 2017 Aug 28. pii: S0090-8258(17)31258.
    PubMed     Text format     Abstract available

    Hum Pathol

  12. SCHOLZ B, Beckert M, Mordstein V, Hohmann N, et al
    Seromucinous borderline tumor of the testis-a case report.
    Hum Pathol. 2016 Sep 2. pii: S0046-8177(16)30206.
    PubMed     Text format     Abstract available

  13. KATO N, Kusumi T, Kamataki A, Tsunoda R, et al
    DICER1 hotspot mutations in ovarian Sertoli-Leydig cell tumors: A potential association with androgenic effects.
    Hum Pathol. 2016 Sep 21. pii: S0046-8177(16)30213.
    PubMed     Text format     Abstract available

  14. ZHANG C, Sung CJ, Quddus MR, Simon RA, et al
    Association of ovarian hyperthecosis with endometrial polyp, endometrial hyperplasia, and endometrioid adenocarcinoma in postmenopausal women: A clinicopathologic study of 238 cases.
    Hum Pathol. 2016 Oct 13. pii: S0046-8177(16)30245.
    PubMed     Text format     Abstract available

  15. LIANG L, Jiang Y, Chen JS, Niu N, et al
    B7-H4 Expression in Ovarian Serous Carcinoma: A Study of 306 Cases.
    Hum Pathol. 2016 Jun 24. pii: S0046-8177(16)30129.
    PubMed     Text format     Abstract available

  16. BRONER EC, Trope CG, Reich R, Davidson B, et al
    TSAP6 is a novel candidate marker of poor survival in metastatic high-grade serous carcinoma.
    Hum Pathol. 2017;60:180-187.
    PubMed     Text format     Abstract available

    Int J Gynaecol Obstet

  17. SON JH, Kong TW, Paek J, Song KH, et al
    Clinical characteristics and prognostic inflection points among long-term survivors of advanced epithelial ovarian cancer.
    Int J Gynaecol Obstet. 2017 Aug 31. doi: 10.1002/ijgo.12315.
    PubMed     Text format     Abstract available

    J Clin Oncol

  18. SAMIMI G, Bernardini MQ, Brody LC, Caga-Anan CF, et al
    Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach.
    J Clin Oncol. 2017;35:2329-2337.
    PubMed     Text format     Abstract available


  19. DE CIAN MC, Pauper E, Bandiera R, Vidal VP, et al
    Amplification of R-spondin1 signaling induces granulosa cell fate defects and cancers in mouse adult ovary.
    Oncogene. 2016 Jun 6. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  20. CORTESI L, De Matteis E, Toss A, Marchi I, et al
    Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study.
    Oncology. 2017 Aug 26. doi: 10.1159/000479155.
    PubMed     Text format     Abstract available

    PLoS One

  21. JIA ZH, Jia Y, Guo FJ, Chen J, et al
    Phosphorylation of STAT3 at Tyr705 regulates MMP-9 production in epithelial ovarian cancer.
    PLoS One. 2017;12:e0183622.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.